Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter

Overexpression of adenine triphosphate (ATP)-binding cassette (ABC) transporters is one of the main reasons of multidrug resistance (MDR) in cancer cells. Trametinib, a novel specific small-molecule mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor, is currently used for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Jian-Ge, Zhang, Yao-Jun, Li, Yong, Zhao, Jin-Ming, Zhang, Wen-Ji, Jiang, Qi-Wei, Mei, Xiao-Long, Xue, You-Qiu, Qin, Wu-Ming, Yang, Yang, Zheng, Di-Wei, Chen, Yao, Wei, Meng-Ning, Shi, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558166/
https://www.ncbi.nlm.nih.gov/pubmed/25915534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558166/
https://www.ncbi.nlm.nih.gov/pubmed/25915534

Ejemplares similares